Quest Diagnostics IncorporatedDGXNYSE
Loading
EBITDA Over TimeExpanding
Percentile Rank86
3Y CAGR+6.4%
5Y CAGR-1.9%
Year-over-Year Change
Earnings before interest, taxes, depreciation, and amortization
3Y CAGR
+6.4%/yr
vs +6.7%/yr prior
5Y CAGR
-1.9%/yr
Recent acceleration
Acceleration
-0.3pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $2.19B | +15.8% |
| 2024 | $1.89B | +9.4% |
| 2023 | $1.73B | -4.8% |
| 2022 | $1.82B | -42.4% |
| 2021 | $3.16B | +31.0% |
| 2020 | $2.41B | +52.1% |
| 2019 | $1.58B | +12.9% |
| 2018 | $1.40B | -3.4% |
| 2017 | $1.45B | -1.8% |
| 2016 | $1.48B | - |